Hepatitis A Lab Interpretation 2026 Update Patient-Friendly A positive antibody result is not a diagnosis by itself. Symptoms, liver chemistry, exposure timing, and the exact assay determine what should happen next. 📖 ~12 minutes 📅 October 18, 2026 📝 Published: October 18, 2026 🩺 Medically Reviewed: October 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and internist with over […]
Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.
Infectious Disease Lab Interpretation 2026 Update Patient-Friendly A positive antibody screen is a clue—not a complete diagnosis. The test method, symptom timeline, and confirmation results determine what that clue means. 📖 ~12 minutes 📅 October 18, 2026 📝 Published: October 18, 2026 🩺 Medically Reviewed: October 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and internist with over 15 […]
Tick-Borne Illness Lab Interpretation 2026 Update Patient-Friendly PCR detects bacterial DNA; antibody tests measure a slower immune response. Early illness and antibiotics can make these results disagree, so treatment sometimes starts before confirmation. 📖 ~12 minutes 📅 October 18, 2026 📝 Published: October 18, 2026 🩺 Medically Reviewed: October 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and internist […]
Genetic Screening Lab Interpretation 2026 Update Patient-Friendly FMR1 results usually fall into four repeat ranges: normal, intermediate, premutation, or full mutation. Carrier status is not the same as fragile X syndrome, and reproductive risk depends on which parent transmits the allele and whether it expands. 📖 ~12 minutes 📅 October 18, 2026 📝 Published: October 18, 2026 🩺 Medically Reviewed: October 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, […]
Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly Low exposure, preferential metabolism and toxicity can produce very different laboratory patterns. The useful question is not simply whether a number is flagged, but whether the treatment is effective and safe for you. 📖 ~12 minutes 📅 October 18, 2026 📝 Published: October 18, 2026 🩺 Medically Reviewed: October 18, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein […]
Medication Genetics Lab Interpretation 2026 Update Patient-Friendly A genetic result can rule out one HIV medicine without diagnosing HIV or an existing allergy. Symptoms after starting abacavir still require action—even when screening was negative. 📖 ~12 minutes 📅 October 17, 2026 📝 Published: October 17, 2026 🩺 Medically Reviewed: October 17, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and […]
Pharmacogenetics Lab Interpretation 2026 Update Patient-Friendly Your inherited enzyme activity can influence how much active clopidogrel you produce. The result helps guide prescribing—it does not give you permission to stop treatment. 📖 ~12 minutes 📅 October 17, 2026 📝 Published: October 17, 2026 🩺 Medically Reviewed: October 17, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and internist with over […]
Red-Cell Membrane Disorders Lab Interpretation 2026 Update Patient-Friendly Reduced fluorescence is a clue to a red-cell membrane disorder—not a diagnosis by itself. The laboratory method, transfusion history, and accompanying evidence of hemolysis determine what that clue means. 📖 ~12 minutes 📅 October 17, 2026 📝 Published: October 17, 2026 🩺 Medically Reviewed: October 17, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified […]
Molecular Hematology Lab Interpretation 2026 Update Patient-Friendly Positive means the fusion was detected; negative means it was not detected by that particular assay. The clinical meaning changes substantially between diagnosis and treatment monitoring. 📖 ~12 minutes 📅 October 17, 2026 📝 Published: October 17, 2026 🩺 Medically Reviewed: October 17, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. Lead Author Thomas Klein, MD Chief Medical Officer, Kantesti AI Dr. Thomas Klein is a board-certified clinical hematologist and internist […]
Autoimmune Blistering Lab Interpretation 2026 Update Patient-Friendly A positive desmoglein antibody test supports pemphigus only when it fits the symptoms and examination. Desmoglein 1 antibodies usually point toward skin involvement; desmoglein 3 antibodies usually point toward mouth involvement. Biopsy with direct immunofluorescence is often needed to confirm the diagnosis, particularly when findings disagree. 📖 ~12 minutes 📅 October 17, 2026 📝 Published: October 17, 2026 🩺 Medically Reviewed: October 17, 2026 ✅ Evidence-Based This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD. […]